Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Kala Pharmaceuticals, Inc., a leading developer of innovative products that rapidly and effectively penetrate the mucosal barrier to treat ocular diseases, announced today that Kala researchers will present preclinical data at the upcoming Controlled Release Society (CRS) 2013 Annual Meeting taking place July 21-24, 2013, in Honolulu, HI. The poster presentation will highlight the capability of Kala’s proprietary Mucosal-Penetrating Particle (MPP) technology to enhance topical drug delivery to the front and back of the eye.
Hey, check out all the research scientist jobs. Post your resume today!
